Concern over cancer gene patent
Steve Connor is the Science Editor of The Independent and i. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; four times highly commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigations into the tobacco industry. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 15 September 1994
This means that any future diagnostic test for breast cancer based on the gene research will be the property of a US biotechnology company - a prospect that worries some British researchers.
Less than 5 per cent of the 27,000 new cases of breast cancer in the UK each year are the result of inherited defects in the breast cancer gene, but the discovery is expected to help understand the other non-inherited cases.
Professor Mark Skolnick, of the University of Utah in Salt Lake City, won the race to find the breast cancer suseptibility gene - BRCA1 - ahead of about a dozen other scientific groups around the world, including at least two in Britain.
He has set up a company, Myriad Genetics, to develop a diagnostic test and to exploit the research commercially. A patent on the gene will protect the millions of dollars spent finding it and making a test, he said yesterday.
Professor Bruce Ponder, of Cambridge University, who was also trying to find the gene, said a number of researchers are concerned about Professor Skolnick's plans to patent the gene. 'Myriad Genetics could end up in a monopoly position. This could make the test more expensive than is necessary,' he said.
Professor Ponder said there are ethical concerns about a diagnostic test that is only relevant to some women and commercial pressures should not dictate when or how the test is introduced.
'We are uneasy about the principle of patenting genes. Finding a gene is just the final step in a pyramid of knowledge and the question is whether it is justifiable for one company to own the patent,' he said.
Professor Skolnick said it will take some time, perhaps a year, before a gene test is developed to help diagnose a breast cancer predisposition in women with a family history of the disease.
Myriad Genetics may charge a fee to scientists who use the patented research, he said. 'It's reasonable for some royalties to be paid.'
A second breast cancer gene was announced yesterday by scientists from the Institute of Cancer Research, in London. Like BRCA1, the second gene increases the risk of breast cancer in some women with a family history of the disease. It may take many years, however, before BRCA2 is finally isolated.
- 1 Katie Hopkins attacked me on Twitter — so I reported her to the police for inciting racial hatred
- 2 Google April Fools': company unveils backwards search engine and huggable digital assistant
- 3 I might be an MP, but that doesn't stop me fighting sexism with my breasts
- 4 April Fools' Day 2015: The best hoax news stories from around the internet
- 5 Gamers confess the worst things they've done in The Sims
Holborn fire: Chaos as 2,000 people evacuated to escape toxic smoke filling central London
University of Cambridge: Remains of 1,300 scholars are found under building
April Fools' Day 2015: The best hoax news stories from around the internet
April Fools' Day 2015 live: The best pranks and fake stories from around the world
Jeremy Clarkson 'could be given minder' ahead of a potential Top Gear return
Street preacher quoting from the Bible fined for calling homosexuality an 'abomination'
Katie Hopkins attacked me on Twitter — so I reported her to the police for inciting racial hatred
Woman filmed launching racist tirade against men on the Tube for speaking in 'own lingo'
David Cameron calls Labour 'hopeless, sneering socialists' while announcing 7-day NHS plans
Revealed: Putin's army of pro-Kremlin bloggers
Katie Hopkins reported to the police for race hatred by Labour MP Simon Danczuk after tweet about Pakistani men
£18000 - £22000 per annum: Recruitment Genius: This is an exciting opportunity...
£30000 - £35000 per annum: Recruitment Genius: Working closely with the market...
£20000 - £50000 per annum: Recruitment Genius: A reputable company, famed for ...
Negotiable: Ashdown Group: The Ashdown Group has been engaged by a highly resp...